BPC157 & TB500 40mg Injection

£115.00

PURCHASE 2 + AND GET EXTRA 1 ADDED FOR FREE.(GET 3 PENS)

24 – 48 HOURS MAXIMUM FOR DELIVERY AND WE PROVIDE TRACK AND TRACE CODE WITH ROYAL MAIL FOR DELIVERY CONFIRMATION SO THAT YOU CAN MONITOR HOW YOUR MEDICINE IS COMING RIGHT TO YOUR ADDRESS WITHOUT ANY HASSLE.

BPC157 & TB500 40mg Injection

Synedica BPC 157 & TB 500 Injection Pen Kit is a cutting-edge peptide supplement for recovery.

TB 500 is renowned for its ability to accelerate healing, reduce inflammation, and improve muscle recovery. It enhances overall physical performance by promoting cell migration, blood vessel formation, and tissue regeneration.

BPC 157 is known for its potent regenerative properties. It accelerates healing by enhancing angiogenesis (the formation of new blood vessels), improving blood flow to damaged areas, and promoting faster tissue repair

Synedica BPC 157 & TB 500 Injection Pen Kit contains 1 pen, 12 disposable needles and an instruction booklet.

70% TB 500 and 30% BPC 157.

Each 3ml pen has 40mg which can be delivered across 4 full doses of 10mg, or in increments of 2.5mg, 5mg, 7.5mg or 10mg. Each dose is 70% TB 500 and 30% BPC 157.

2.5mg = 1.75mg TB 500, 0.75mg BPC 157
5mg = 3.5mg TB 500, 1mg BPC 157
7.5mg = 5.25mg TB 500, 2.25mg BPC 157
10mg = 7mg TB 500, 3mg BPC 157

Recommended dosage is 5mg taken 2 or 3 times a week.

⚠️ Important Notice

All products are produced exclusively for controlled laboratory research and development applications.
Not for human or animal consumption.

Suitable R&D Applications

 Stability Testing

  • Thermal, enzymatic, and oxidative degradation studies

  • Shelf-life evaluation & formulation robustness

 Formulation Development

  • Enhances solubility, bioavailability, and structural integrity

  • Tailored for injectable, topical, and research-grade use

 Excipient Compatibility Testing

  • Evaluates interactions between peptides & inactive components

  • Ensures safety, stability, and performance

Protease Resistance Evaluation

  • Assesses susceptibility to enzymatic breakdown

  • Supports development of more durable peptide products

 Encapsulation & Carrier Systems

  • Liposomes, microspheres, and other delivery vehicles

  • Protects peptides & enables controlled release

Administration Route Assessment

Optimized for:

  • Parenteral delivery (injectables)

  • Dermal absorption (cosmetic/topical)

  • In vitro research applications